DAT indicated enrichment of a population of IL1R2-high neutrophils in patients with MASLD that further exhibited elevated expression of, eg, PHACTR1, NEAT1, MALAT1, CPQ, CELF2, and CFLAR. This evidence concerns the gene CFLAR and metabolic dysfunction-associated steatotic liver disease.